Urinary Bladder Neoplasm

Click here to read the Cover Story, “BCG: a real-world example of health care rationing.”

Erdafitinib induced a high rate of objective tumor response in patients with locally advanced and unresectable or metastatic urothelial carcinoma with FGFR alterations, according to results of a single-arm phase 2 study published in The New England Journal of Medicine.